D.E. Shaw & Co
CLLS

D.E. Shaw & Co’s Cellectis CLLS Stock Holding History

D.E. Shaw & Co’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-47,154
Closed -$74.5K – 4348
2023
Q3 		$74.5K Sell
47,154
-31,675
-40% -$61.9K ﹤0.01% 3880
2023
Q2 		$155K Sell
78,829
-43,701
-36% -$83.8K ﹤0.01% 3786
2023
Q1 		$236K Sell
122,530
-104,582
-46% -$262K ﹤0.01% 3843
2022
Q4 		$477K Sell
227,112
-51,215
-18% -$116K ﹤0.01% 3879
2022
Q3 		$637K Buy
278,327
+6,778
+2% +$20.5K ﹤0.01% 3889
2022
Q2 		$768K Sell
271,549
-28,138
-9% -$99.1K ﹤0.01% 3800
2022
Q1 		$1.36M Buy
299,687
+108,744
+57% +$599K ﹤0.01% 3654
2021
Q4 		$1.55M Buy
190,943
+102,421
+116% +$1.01M ﹤0.01% 3579
2021
Q3 		$1.12M Sell
88,522
-6,747
-7% -$93.5K ﹤0.01% 3516
2021
Q2 		$1.47M Sell
95,269
-3,431
-3% -$57.7K ﹤0.01% 3228
2021
Q1 		$2M Sell
98,700
-19,971
-17% -$494K ﹤0.01% 2588
2020
Q4 		$3.21M Buy
118,671
+1,610
+1% +$36.1K ﹤0.01% 2217
2020
Q3 		$2.17M Sell
117,061
-88,084
-43% -$1.56M ﹤0.01% 2343
2020
Q2 		$3.65M Buy
205,145
+79,929
+64% +$1.22M ﹤0.01% 1911
2020
Q1 		$1.15M Sell
125,216
-67,114
-35% -$1M ﹤0.01% 2635
2019
Q4 		$3.29M Buy
192,330
+55,107
+40% +$736K ﹤0.01% 2071
2019
Q3 		$1.43M Buy
137,223
+105,023
+326% +$1.41M ﹤0.01% 2606
2019
Q2 		$502K Buy
+32,200
New +$575K ﹤0.01% 3085
2018
Q2 		– Sell
-35,705
Closed -$1.13M – 3717
2018
Q1 		$1.13M Buy
+35,705
New +$1.13M ﹤0.01% 2409

Other funds holding CLLS

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

D.E. Shaw & Co's CLLS Position: Q4 2023 in Review

D.E. Shaw & Co sold out of Cellectis (CLLS) in Q4 2023, closing a stake of 47,154 shares — an estimated $74.5K sold.

D.E. Shaw & Co first reported a position in CLLS in Q1 2018 and held it in 19 quarters. The position peaked at $3.65M in Q2 2020. 34 funds tracked by Wall St. Rank hold CLLS as of Q4 2023.

  • D.E. Shaw & Co reported no remaining Cellectis position as of Q4 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 47,154 Cellectis shares in Q4 2023, an estimated $74.5K.
  • D.E. Shaw & Co first reported a position in Cellectis in Q1 2018 and held it in 19 quarters.
  • D.E. Shaw & Co's Cellectis position peaked at $3.65M in Q2 2020.
  • 34 funds tracked by Wall St. Rank held Cellectis as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.